Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Jun 19, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 125,000 | -- |
| Jun 19, 2019 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 3,535 | $8.49 |
| Jun 06, 2019 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 18,240 | $7.95 |
| May 29, 2019 |
Director
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 50,000 | $6.09 |
| May 29, 2019 |
Director
|
Director | Open market or private sale of non-derivative or derivative security | 42,643 | $7.75 |
| May 29, 2019 |
Director
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 50,000 | -- |
| May 28, 2019 |
Director
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 44,929 | $6.09 |
| May 28, 2019 |
Director
|
Director | Open market or private sale of non-derivative or derivative security | 37,385 | $8.00 |
| May 28, 2019 |
Director
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 44,929 | -- |
| May 24, 2019 |
Director
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,071 | $6.09 |
| May 24, 2019 |
Director
|
Director | Open market or private sale of non-derivative or derivative security | 5,071 | $7.94 |
| May 24, 2019 |
Director
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,071 | -- |
| May 16, 2019 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 22,702 | $8.54 |
| May 14, 2019 |
SVP and Chief Legal Officer
|
SVP and Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 458 | $8.82 |
| May 14, 2019 |
SVP and Chief Legal Officer
|
SVP and Chief Legal Officer | Other acquisition or disposition | -- | -- |
| May 14, 2019 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 2,388 | $8.82 |
| May 14, 2019 |
EVP, COO & CCO
|
EVP, COO & CCO | Other acquisition or disposition | -- | -- |
| May 13, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,000 | $8.93 |
| Apr 12, 2019 |
SVP and Chief Legal Officer
|
SVP and Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Apr 12, 2019 |
EVP, COO & CCO
|
EVP, COO & CCO | Other acquisition or disposition | -- | -- |
| Apr 11, 2019 |
Director
|
Director | Open market or private sale of non-derivative or derivative security | 10,738 | $10.67 |
| Apr 11, 2019 |
SVP and Chief Legal Officer
|
SVP and Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 2,018 | $10.67 |
| Apr 11, 2019 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 16,493 | $10.75 |
| Apr 03, 2019 |
SVP and Chief Legal Officer
|
SVP and Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Apr 03, 2019 |
EVP, COO & CCO
|
EVP, COO & CCO | Other acquisition or disposition | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.